Effect of in utero-administered coumestrol, equol, and organic selenium on biomarkers for phase 2 enzyme capacity and redox status

Nutrition and Cancer

Volumn 46, Issue 1, 2003, Pages 73-81

  Kramer, Franziska ^a   Jensen, Pia S ^a   Vinggaard, Anne M ^a   Larsen, Erik H ^a   Breinholt, Vibeke M ^a  

^a DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COUMESTROL; EQUOL; ESTRADIOL; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SELENIUM;

ANIMAL EXPERIMENT; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; OXIDATION REDUCTION REACTION; PREGNANCY; RAT;

ANIMALIA;

EID: 0141848320     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4601_10     Document Type: Article

References (50)

1. Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103 Suppl 7, 103-112, 1995.
2. Messina M and Barnes S: The role of soy products in reducing risk of cancer. JNCI 83, 541-546, 1991.
3. Lamartiniere CA: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 71, 1705S-1707S; discussion 1708S-1709S, 2000.
4. Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, et al.: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457, 1996.
5. Breinholt V and Larsen JC: Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 11, 622-629, 1998.
6. Breinholt V, Hossaini A, Svendsen GW, Brouwer C, and Nielsen E: Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol 38, 555-564, 2000.
7. Markiewicz L, Garey J, Adlercreutz H, and Gurpide E: In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 45, 399-405, 1993.
8. Appelt LC and Reicks MM: Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J Nutr 129, 1820-1826, 1999.
9. Wang W, Liu LQ, Higuchi CM, and Chen H: Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol 56, 189-195, 1998.
10. Yannai S, Day AJ, Williamson G, and Rhodes MJ: Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. Food Chem Toxicol 36, 623-630, 1998.
11. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, and Clarke R: Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6, 1089-1095, 1999.
12. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, et al.: Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80, 1682-1688, 1999.
13. Yang J, Nakagawa H, Tsuta K, and Tsubura A: Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Lett 149, 171-179, 2000.
14. Allred CD, Ju YH, Allred KF, Chang J, and Helferich WG: Dietary genistein stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22, 1667-1673, 2001.
15. Ju YH, Doerge DR, Allred KF, Allred CD, and Helferich WG: Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res 62, 2474-2477, 2002.
16. Brown NM and Lamartiniere CA: Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Perspect 103, 708-713, 1995.
17. Hilakivi-Clarke L, Clarke R, and Lippman ME: Perinatal factors increase breast cancer risk. Breast Cancer Res Treat 31, 273-284, 1994.
18. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, et al.: Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 5, 901-906, 1996.
19. Clark LC and Alberts DS: Selenium and cancer: risk or protection? JNCI 87, 473-475, 1995.
20. Ip C: The chemopreventive role of selenium in carcinogenesis. Adv Exp Med Biol 206, 431-447, 1986.
21. Gong Y and Frenkel GD: Effect of selenite on tumor cell invasiveness. Cancer Lett 78, 195-199, 1994.
22. Ip C and Daniel FB: Effects of selenium on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis and DNA adduct formation. Cancer Res 45, 61-65, 1985.
23. Lake BG: Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism. In Biochemical Toxicology: A Practical Approach, K. Snell and B. Mullock (eds). Oxford, England: IRL Press, 1987, pp 183-215.
24. Nielsen SE, Breinholt V, Justesen U, Cornett C, and Dragsted LO: In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28, 389-401, 1998.
25. Sloth JJ and Larsen EH: The application of inductively coupled plasma dynamic reaction cell mass spectrometry for measurement of selenium isotopes, isotope ratios and chromatographic detection of seleno amino acids. J Anal At Spectrom 15, 669-672, 2000.
26. Burke MD, Thompson S, Weaver RJ, Wolf CR, and Mayer RT: Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48, 923-936, 1994.
27. Breinholt V, Lauridsen ST, Daneshvar B, and Jakobsen J: Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett 154, 201-210, 2000.
28. Ernster L: DT diaphorase. Methods Enzymol 10, 309-317, 1967.
29. Habig WH, Keen JH, and Jakoby WB: Glutathione S-transferase in the formation of cyanide from organic thiocyantes and as an organic nitrate reductase. Biochem Biophys Res Commun 64, 501-506, 1975.
30. Redinbaugh MG and Turley RB: Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Anal Biochem 153, 267-271, 1986.
31. Carbonneau MA, Peuchant E, Sess D, Canioni P, and Clerc M: Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma. Clin Chem 37, 1423-1429, 1991.
32. Clarkson TB and Anthony MS: Phytoestrogens and coronary heart disease. Clin Endocrinol Metab 12, 589-604, 1998.
33. Whitten PL, Lewis C, Russell E, and Naftolin F: Potential adverse effects of phytoestrogens. J Nutr 125 Suppl 3, 771S-776S, 1995.
34. McLachlan JA, Newbold RR, Li S, and Negishi M: Are estrogens carcinogenic during development of the testes? Apmis 106, 240-242; discussion 243-244, 1998.
35. Smith PJ, Tappel AL, and Chow CK: Glutathione peroxidase activity as a function of dietary selenomethionine. Nature 247, 392-393, 1974.
36. Yasumoto K, Iwami K, and Yoshida M: Vitamin B6 dependence of selenomethionine and selenite utilization for glutathione peroxidase in the rat. J Nutr 109, 760-766, 1979.
37. Kravchenko LV, Kuz'mina EE, Avren'eva LI, and Pozdniakov AL: The effect of selenium on enzymes metabolizing xenobiotics in rat liver. Vopr Med Khim 37, 73-76, 1991.
38. Thompson HJ and Ip C: Temporal changes in tissue glutathione in response to chemical form, dose, and duration of selenium treatment. Relevance to cancer chemoprevention by selenium. Biol Trace Elem Res 30, 163-173, 1991.
39. Alfthan G and Neve J: Reference values for serum selenium in various areas evaluated according to the TRACY protocol. J Trace Elem Med Biol 10, 77-87, 1996.
40. Ip C, Birringer M, Block E, Kotrebai M, Tyson JF, et al.: Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 48, 2062-2070, 2000.
41. Serafini MT, Arola L, and Romeu A: Glutathione and related enzyme activity in the 11-day rat embryo, placenta and perinatal rat liver. Biol Neonate 60, 236-242, 1991.
42. Adlercreutz H, Markkanen H, and Watanabe S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210, 1993.
43. Helsby NA, Williams J, Kerr D, Gescher A, and Chipman JK: The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. Xenobiotica 27, 587-596, 1997.
44. Helsby NA, Chipman JK, Gescher A, and Kerr D: Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol 36, 375-382, 1998.
45. de Wildt SN, Kearns GL, Leeder JS, and van den Anker JN: Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 37, 485-505, 1999.
46. He YH, Friesen MD, Ruch RJ, and Schut HA: Indole-3-carbinol as a chemopreventive agent in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenesis: inhibition of PhIP-DNA adduct formation, acceleration of PhIP metabolism, and induction of cytochrome P450 in female F344 rats. Food Chem Toxicol 38, 15-23, 2000.
47. Stresser DM, Bailey GS, and Williams DE: Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Drug Metab Dispos 22, 383-391, 1994.
48. Gunther T, Hollriegl V, and Vormann J: Perinatal development of iron and antioxidant defence systems. J Trace Elem Electrolytes Health Dis 7, 47-52, 1993.
49. Ekbom A, Trichopoulus D, Adami HO, Hsieh CC, and Lan SJ: Evidence of prenatal influences on breast cancer risk. Lancet 340, 1015-1018, 1992.
50. Milligan SR, Balasubramanian AV, and Kalita JC: Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay. Environ Health Perspect 106, 23-26, 1998.